Ryvu Therapeutics
Polish cancer drug developer
Ryvu Therapeutics has raised €22M across 1 funding round from 2 investors, most recently a round in Aug 2022. Based in Warsaw, Poland; active in Healthtech. Data as of Nov 2026.
Warsaw, Polandryvu.com ↗
Total raised
€22M
€22,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-08
latest 2022-08
Funding by year
EUR raised per yearRyvu Therapeutics — funding by year — interactive chart.
Data table
| Ryvu Therapeutics — funding by year | |
|---|---|
| 2022 | €22M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-17 | Other | €22M | European Fund for Strategic Investments,European Investment Bank (EIB) | View deal → |
Related news
Similar companies
same sector, similar size- Genomtec€17MPoland · Healthtech
- Infermedica€38MPoland · Healthtech
- Scope Fluidics€19MPoland · Healthtech
- Mindgram€11MPoland · Healthtech
- WishBone Medical€17MPoland · Healthtech
- Quantum Innovations€10MPoland · Healthtech
Global coverage: FundingData